These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 29157621)

  • 1. Treatment of Kaposi Sarcoma Herpesvirus-Associated Multicentric Castleman Disease.
    Lurain K; Yarchoan R; Uldrick TS
    Hematol Oncol Clin North Am; 2018 Feb; 32(1):75-88. PubMed ID: 29157621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in Kaposi sarcoma herpesvirus-associated multicentric Castleman disease.
    Uldrick TS; Polizzotto MN; Yarchoan R
    Curr Opin Oncol; 2012 Sep; 24(5):495-505. PubMed ID: 22729151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose zidovudine plus valganciclovir for Kaposi sarcoma herpesvirus-associated multicentric Castleman disease: a pilot study of virus-activated cytotoxic therapy.
    Uldrick TS; Polizzotto MN; Aleman K; O'Mahony D; Wyvill KM; Wang V; Marshall V; Pittaluga S; Steinberg SM; Tosato G; Whitby D; Little RF; Yarchoan R
    Blood; 2011 Jun; 117(26):6977-86. PubMed ID: 21487108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rituximab plus liposomal doxorubicin in HIV-infected patients with KSHV-associated multicentric Castleman disease.
    Uldrick TS; Polizzotto MN; Aleman K; Wyvill KM; Marshall V; Whitby D; Wang V; Pittaluga S; O'Mahony D; Steinberg SM; Little RF; Yarchoan R
    Blood; 2014 Dec; 124(24):3544-52. PubMed ID: 25331113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coexistence of disseminated Kaposi sarcoma and multicentric Castleman disease in an HIV-infected patient under viral suppression.
    Lin IF; Lin JN; Tsai TH; Hsu CT; Wu YY; Lai CH
    Int J STD AIDS; 2021 Mar; 32(3):286-289. PubMed ID: 33555231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics and outcomes of KSHV-associated multicentric Castleman disease with or without other KSHV diseases.
    Ramaswami R; Lurain K; Polizzotto MN; Ekwede I; Waldon K; Steinberg SM; Mangusan R; Widell A; Rupert A; George J; Gonçalves PH; Marshall VA; Whitby D; Wang HW; Pittaluga S; Jaffe ES; Little RF; Uldrick TS; Yarchoan R
    Blood Adv; 2021 Mar; 5(6):1660-1670. PubMed ID: 33720337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kaposi sarcoma herpesvirus-associated cancers and related diseases.
    Goncalves PH; Ziegelbauer J; Uldrick TS; Yarchoan R
    Curr Opin HIV AIDS; 2017 Jan; 12(1):47-56. PubMed ID: 27662501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Durable remission of both multicentric Castleman's disease and Kaposi's sarcoma with valganciclovir, rituximab and liposomal doxorubicin in an HHV-8-positive, HIV-negative patient.
    Murphy C; Hawkes E; Chionh F; Chong G
    J Clin Pharm Ther; 2017 Feb; 42(1):111-114. PubMed ID: 27790727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow findings in HIV-positive patients with Kaposi sarcoma herpesvirus-associated multicentric Castleman disease.
    Venkataraman G; Uldrick TS; Aleman K; O'Mahony D; Karcher DS; Steinberg SM; Raffeld MA; Marshall V; Whitby D; Little RF; Yarchoan R; Pittaluga S; Maric I
    Am J Clin Pathol; 2013 May; 139(5):651-61. PubMed ID: 23596117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human and viral interleukin-6 and other cytokines in Kaposi sarcoma herpesvirus-associated multicentric Castleman disease.
    Polizzotto MN; Uldrick TS; Wang V; Aleman K; Wyvill KM; Marshall V; Pittaluga S; O'Mahony D; Whitby D; Tosato G; Steinberg SM; Little RF; Yarchoan R
    Blood; 2013 Dec; 122(26):4189-98. PubMed ID: 24174627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A HHV-8 positive, HIV negative multicentric Castleman disease treated with R-CEOP chemotherapy and valganciclovir combination.
    Kantarci FE; Eren R; Gündoğan C; Huq GE; Doğu MH; Suyanı E
    J Infect Chemother; 2016 Jul; 22(7):483-5. PubMed ID: 26948831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human Herpesvirus Type 8-positive Multicentric Castleman Disease.
    Melikyan AL; Egorova EK; Julhakyan HL; Kovrigina AL; Savchenko VG
    Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S159-65. PubMed ID: 27133959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-associated multicentric Castleman disease.
    Oksenhendler E
    Curr Opin HIV AIDS; 2009 Jan; 4(1):16-21. PubMed ID: 19343828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KSHV-associated multicentric Castleman disease: A tangle of different entities requiring multitarget treatment strategies.
    Carbone A; De Paoli P; Gloghini A; Vaccher E
    Int J Cancer; 2015 Jul; 137(2):251-61. PubMed ID: 24771491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicentric Castleman disease of hyaline vascular variant presenting with unusual systemic manifestations: a case report.
    Basnayake BMDB; Wazil AWM; Kannangara T; Ratnatunga NVI; Hewamana S; Ameer AM
    J Med Case Rep; 2017 May; 11(1):135. PubMed ID: 28501028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 18F-fluorodeoxyglucose Positron Emission Tomography in Kaposi Sarcoma Herpesvirus-Associated Multicentric Castleman Disease: Correlation With Activity, Severity, Inflammatory and Virologic Parameters.
    Polizzotto MN; Millo C; Uldrick TS; Aleman K; Whatley M; Wyvill KM; O'Mahony D; Marshall V; Whitby D; Maass-Moreno R; Steinberg SM; Little RF; Yarchoan R
    J Infect Dis; 2015 Oct; 212(8):1250-60. PubMed ID: 25828248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicentric Castleman disease and the evolution of the concept.
    Zhou T; Wang HW; Pittaluga S; Jaffe ES
    Pathologica; 2021 Oct; 113(5):339-353. PubMed ID: 34837092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kaposi sarcoma-associated herpesvirus infects monotypic (IgM lambda) but polyclonal naive B cells in Castleman disease and associated lymphoproliferative disorders.
    Du MQ; Liu H; Diss TC; Ye H; Hamoudi RA; Dupin N; Meignin V; Oksenhendler E; Boshoff C; Isaacson PG
    Blood; 2001 Apr; 97(7):2130-6. PubMed ID: 11264181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tocilizumab in patients with symptomatic Kaposi sarcoma herpesvirus-associated multicentric Castleman disease.
    Ramaswami R; Lurain K; Peer CJ; Serquiña A; Wang V; Widell A; Goncalves P; Steinberg SM; Marshall V; George J; Figg WD; Whitby D; Ziegelbauer J; Uldrick TS; Yarchoan R
    Blood; 2020 Jun; 135(25):2316-2319. PubMed ID: 32276276
    [No Abstract]   [Full Text] [Related]  

  • 20. Kaposi sarcoma herpes virus-associated hemophagocytic syndrome complicated by multicentric castleman disease and kaposi sarcoma in a HIV-negative immunocompetent patient: an autopsy case.
    Kim B; Jeon YK; Kim CW
    J Korean Med Sci; 2009 Oct; 24(5):970-4. PubMed ID: 19795003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.